Mallinckrodt plc (AMEX: MNK) Stock Competitors & Peer Comparison
See MNK's competitors and their performance on the AMEX and across the wider stock market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for MNK and its AMEX peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| MNK | $0.34 | -14.97% | 4.5M | -0.44 | -$0.78 | N/A |
| TAK | $17.45 | +2.53% | 55.5B | 12.55 | $1.39 | +3.61% |
| HLN | $10.03 | +0.00% | 44.2B | 25.11 | $0.40 | +1.76% |
| TEVA | $35.36 | +1.58% | 41.2B | 12.06 | $2.93 | N/A |
| VTRS | $16.43 | +0.86% | 19.1B | 6.52 | $2.52 | +2.90% |
| ITCI | $131.87 | +0.00% | 14B | -180.64 | -$0.73 | N/A |
| CTLT | $63.48 | +0.00% | 11.5B | -27.84 | -$2.28 | N/A |
| ELAN | $22.12 | -8.60% | 11B | 20.86 | $1.06 | N/A |
| RDY | $12.22 | +0.91% | 10.2B | 20.01 | $0.61 | +0.68% |
| LNTH | $100.95 | -0.12% | 6.6B | 16.97 | $5.95 | N/A |
Stock Comparison
Takeda Pharmaceutical Company Limited (NYSE: TAK)
MNK vs TAK Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, TAK has a market cap of 55.5B. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while TAK trades at $17.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas TAK's P/E ratio is 12.55. In terms of profitability, MNK's ROE is -0.26%, compared to TAK's ROE of +0.02%. Regarding short-term risk, MNK is more volatile compared to TAK. This indicates higher risk in terms of short-term price fluctuations for MNK.Check TAK's competition here
Haleon plc (NYSE: HLN)
MNK vs HLN Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, HLN has a market cap of 44.2B. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while HLN trades at $10.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas HLN's P/E ratio is 25.11. In terms of profitability, MNK's ROE is -0.26%, compared to HLN's ROE of +0.17%. Regarding short-term risk, MNK is more volatile compared to HLN. This indicates higher risk in terms of short-term price fluctuations for MNK.Check HLN's competition here
Teva Pharmaceutical Industries Limited (NYSE: TEVA)
MNK vs TEVA Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, TEVA has a market cap of 41.2B. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while TEVA trades at $35.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas TEVA's P/E ratio is 12.06. In terms of profitability, MNK's ROE is -0.26%, compared to TEVA's ROE of +0.09%. Regarding short-term risk, MNK is more volatile compared to TEVA. This indicates higher risk in terms of short-term price fluctuations for MNK.Check TEVA's competition here
Viatris Inc. (NASDAQ: VTRS)
MNK vs VTRS Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, VTRS has a market cap of 19.1B. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while VTRS trades at $16.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas VTRS's P/E ratio is 6.52. In terms of profitability, MNK's ROE is -0.26%, compared to VTRS's ROE of -0.03%. Regarding short-term risk, MNK is more volatile compared to VTRS. This indicates higher risk in terms of short-term price fluctuations for MNK.Check VTRS's competition here
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI)
MNK vs ITCI Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, ITCI has a market cap of 14B. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while ITCI trades at $131.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas ITCI's P/E ratio is -180.64. In terms of profitability, MNK's ROE is -0.26%, compared to ITCI's ROE of -0.09%. Regarding short-term risk, MNK is more volatile compared to ITCI. This indicates higher risk in terms of short-term price fluctuations for MNK.Check ITCI's competition here
Catalent, Inc. (NYSE: CTLT)
MNK vs CTLT Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, CTLT has a market cap of 11.5B. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while CTLT trades at $63.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas CTLT's P/E ratio is -27.84. In terms of profitability, MNK's ROE is -0.26%, compared to CTLT's ROE of -0.25%. Regarding short-term risk, MNK is more volatile compared to CTLT. This indicates higher risk in terms of short-term price fluctuations for MNK.Check CTLT's competition here
Elanco Animal Health Incorporated (NYSE: ELAN)
MNK vs ELAN Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, ELAN has a market cap of 11B. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while ELAN trades at $22.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas ELAN's P/E ratio is 20.86. In terms of profitability, MNK's ROE is -0.26%, compared to ELAN's ROE of -0.03%. Regarding short-term risk, MNK is more volatile compared to ELAN. This indicates higher risk in terms of short-term price fluctuations for MNK.Check ELAN's competition here
Dr. Reddy's Laboratories Limited (NYSE: RDY)
MNK vs RDY Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, RDY has a market cap of 10.2B. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while RDY trades at $12.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas RDY's P/E ratio is 20.01. In terms of profitability, MNK's ROE is -0.26%, compared to RDY's ROE of +0.09%. Regarding short-term risk, MNK is more volatile compared to RDY. This indicates higher risk in terms of short-term price fluctuations for MNK.Check RDY's competition here
Lantheus Holdings, Inc. (NASDAQ: LNTH)
MNK vs LNTH Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, LNTH has a market cap of 6.6B. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while LNTH trades at $100.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas LNTH's P/E ratio is 16.97. In terms of profitability, MNK's ROE is -0.26%, compared to LNTH's ROE of +0.23%. Regarding short-term risk, MNK is more volatile compared to LNTH. This indicates higher risk in terms of short-term price fluctuations for MNK.Check LNTH's competition here
Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX)
MNK vs AMRX Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, AMRX has a market cap of 5.8B. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while AMRX trades at $18.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas AMRX's P/E ratio is 20.16. In terms of profitability, MNK's ROE is -0.26%, compared to AMRX's ROE of -3.27%. Regarding short-term risk, MNK is more volatile compared to AMRX. This indicates higher risk in terms of short-term price fluctuations for MNK.Check AMRX's competition here
Indivior Pharmaceuticals Inc (NASDAQ: INDV)
MNK vs INDV Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, INDV has a market cap of 4.8B. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while INDV trades at $38.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas INDV's P/E ratio is 10.64. In terms of profitability, MNK's ROE is -0.26%, compared to INDV's ROE of -2.16%. Regarding short-term risk, MNK is more volatile compared to INDV. This indicates higher risk in terms of short-term price fluctuations for MNK.Check INDV's competition here
Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN)
MNK vs SUPN Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, SUPN has a market cap of 2.8B. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while SUPN trades at $47.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas SUPN's P/E ratio is 15.57. In terms of profitability, MNK's ROE is -0.26%, compared to SUPN's ROE of -0.10%. Regarding short-term risk, MNK is more volatile compared to SUPN. This indicates higher risk in terms of short-term price fluctuations for MNK.Check SUPN's competition here
Regencell Bioscience Holdings Limited (NASDAQ: RGC)
MNK vs RGC Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, RGC has a market cap of 2.7B. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while RGC trades at $5.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas RGC's P/E ratio is -380.99. In terms of profitability, MNK's ROE is -0.26%, compared to RGC's ROE of -2.32%. Regarding short-term risk, MNK is more volatile compared to RGC. This indicates higher risk in terms of short-term price fluctuations for MNK.Check RGC's competition here
Bausch Health Companies Inc. (NYSE: BHC)
MNK vs BHC Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, BHC has a market cap of 2.3B. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while BHC trades at $6.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas BHC's P/E ratio is 1.59. In terms of profitability, MNK's ROE is -0.26%, compared to BHC's ROE of +0.89%. Regarding short-term risk, MNK is more volatile compared to BHC. This indicates higher risk in terms of short-term price fluctuations for MNK.Check BHC's competition here
Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH)
MNK vs DCPH Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, DCPH has a market cap of 2.2B. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while DCPH trades at $25.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas DCPH's P/E ratio is -11.58. In terms of profitability, MNK's ROE is -0.26%, compared to DCPH's ROE of -0.56%. Regarding short-term risk, MNK is more volatile compared to DCPH. This indicates higher risk in terms of short-term price fluctuations for MNK.Check DCPH's competition here
HUTCHMED (China) Limited (NASDAQ: HCM)
MNK vs HCM Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, HCM has a market cap of 2.2B. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while HCM trades at $12.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas HCM's P/E ratio is 4.69. In terms of profitability, MNK's ROE is -0.26%, compared to HCM's ROE of +0.01%. Regarding short-term risk, MNK is more volatile compared to HCM. This indicates higher risk in terms of short-term price fluctuations for MNK.Check HCM's competition here
Avadel Pharmaceuticals plc (NASDAQ: AVDL)
MNK vs AVDL Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, AVDL has a market cap of 2.1B. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while AVDL trades at $21.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas AVDL's P/E ratio is -1082.00. In terms of profitability, MNK's ROE is -0.26%, compared to AVDL's ROE of +0.05%. Regarding short-term risk, MNK is more volatile compared to AVDL. This indicates higher risk in terms of short-term price fluctuations for MNK.Check AVDL's competition here
Embecta Corp. (NASDAQ: EMBCV)
MNK vs EMBCV Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, EMBCV has a market cap of 1.9B. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while EMBCV trades at $33.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas EMBCV's P/E ratio is N/A. In terms of profitability, MNK's ROE is -0.26%, compared to EMBCV's ROE of -0.19%. Regarding short-term risk, MNK is more volatile compared to EMBCV. This indicates higher risk in terms of short-term price fluctuations for MNK.Check EMBCV's competition here
Dynavax Technologies Corporation (NASDAQ: DVAX)
MNK vs DVAX Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, DVAX has a market cap of 1.8B. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while DVAX trades at $15.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas DVAX's P/E ratio is -41.89. In terms of profitability, MNK's ROE is -0.26%, compared to DVAX's ROE of -0.10%. Regarding short-term risk, MNK is more volatile compared to DVAX. This indicates higher risk in terms of short-term price fluctuations for MNK.Check DVAX's competition here
ANI Pharmaceuticals, Inc. (NASDAQ: ANIP)
MNK vs ANIP Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, ANIP has a market cap of 1.8B. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while ANIP trades at $78.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas ANIP's P/E ratio is 9.52. In terms of profitability, MNK's ROE is -0.26%, compared to ANIP's ROE of +0.19%. Regarding short-term risk, MNK is more volatile compared to ANIP. This indicates higher risk in terms of short-term price fluctuations for MNK.Check ANIP's competition here
Perrigo Company plc (NYSE: PRGO)
MNK vs PRGO Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, PRGO has a market cap of 1.8B. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while PRGO trades at $12.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas PRGO's P/E ratio is 5.13. In terms of profitability, MNK's ROE is -0.26%, compared to PRGO's ROE of -0.56%. Regarding short-term risk, MNK is more volatile compared to PRGO. This indicates higher risk in terms of short-term price fluctuations for MNK.Check PRGO's competition here
Taro Pharmaceutical Industries Ltd. (NYSE: TARO)
MNK vs TARO Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, TARO has a market cap of 1.6B. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while TARO trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas TARO's P/E ratio is 30.05. In terms of profitability, MNK's ROE is -0.26%, compared to TARO's ROE of +0.03%. Regarding short-term risk, MNK is more volatile compared to TARO. This indicates higher risk in terms of short-term price fluctuations for MNK.Check TARO's competition here
Harrow Health, Inc. (NASDAQ: HROW)
MNK vs HROW Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, HROW has a market cap of 1.5B. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while HROW trades at $40.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas HROW's P/E ratio is 449.33. In terms of profitability, MNK's ROE is -0.26%, compared to HROW's ROE of -0.34%. Regarding short-term risk, MNK is more volatile compared to HROW. This indicates higher risk in terms of short-term price fluctuations for MNK.Check HROW's competition here
Phibro Animal Health Corporation (NASDAQ: PAHC)
MNK vs PAHC Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, PAHC has a market cap of 1.4B. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while PAHC trades at $34.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas PAHC's P/E ratio is 11.70. In terms of profitability, MNK's ROE is -0.26%, compared to PAHC's ROE of +0.29%. Regarding short-term risk, MNK is more volatile compared to PAHC. This indicates higher risk in terms of short-term price fluctuations for MNK.Check PAHC's competition here
Alvotech (NASDAQ: ALVO)
MNK vs ALVO Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, ALVO has a market cap of 1.3B. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while ALVO trades at $3.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas ALVO's P/E ratio is -11.21. In terms of profitability, MNK's ROE is -0.26%, compared to ALVO's ROE of +0.35%. Regarding short-term risk, MNK is more volatile compared to ALVO. This indicates higher risk in terms of short-term price fluctuations for MNK.Check ALVO's competition here
Eton Pharmaceuticals, Inc. (NASDAQ: ETON)
MNK vs ETON Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, ETON has a market cap of 1.2B. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while ETON trades at $44.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas ETON's P/E ratio is -637.14. In terms of profitability, MNK's ROE is -0.26%, compared to ETON's ROE of -0.06%. Regarding short-term risk, MNK is more volatile compared to ETON. This indicates higher risk in terms of short-term price fluctuations for MNK.Check ETON's competition here
Cronos Group Inc. (NASDAQ: CRON)
MNK vs CRON Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, CRON has a market cap of 1.2B. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while CRON trades at $3.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas CRON's P/E ratio is 29.44. In terms of profitability, MNK's ROE is -0.26%, compared to CRON's ROE of +0.06%. Regarding short-term risk, MNK is more volatile compared to CRON. This indicates higher risk in terms of short-term price fluctuations for MNK.Check CRON's competition here
Pacira BioSciences, Inc. (NASDAQ: PCRX)
MNK vs PCRX Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, PCRX has a market cap of 984.2M. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while PCRX trades at $25.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas PCRX's P/E ratio is 9.62. In terms of profitability, MNK's ROE is -0.26%, compared to PCRX's ROE of +0.02%. Regarding short-term risk, MNK is more volatile compared to PCRX. This indicates higher risk in terms of short-term price fluctuations for MNK.Check PCRX's competition here
Collegium Pharmaceutical, Inc. (NASDAQ: COLL)
MNK vs COLL Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, COLL has a market cap of 955.8M. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while COLL trades at $29.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas COLL's P/E ratio is 3.70. In terms of profitability, MNK's ROE is -0.26%, compared to COLL's ROE of +0.16%. Regarding short-term risk, MNK is more volatile compared to COLL. This indicates higher risk in terms of short-term price fluctuations for MNK.Check COLL's competition here
PetIQ, Inc. (NASDAQ: PETQ)
MNK vs PETQ Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, PETQ has a market cap of 919.2M. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while PETQ trades at $30.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas PETQ's P/E ratio is 83.73. In terms of profitability, MNK's ROE is -0.26%, compared to PETQ's ROE of +0.01%. Regarding short-term risk, MNK is more volatile compared to PETQ. This indicates higher risk in terms of short-term price fluctuations for MNK.Check PETQ's competition here
Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH)
MNK vs AMPH Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, AMPH has a market cap of 916.3M. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while AMPH trades at $20.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas AMPH's P/E ratio is 7.09. In terms of profitability, MNK's ROE is -0.26%, compared to AMPH's ROE of +0.10%. Regarding short-term risk, MNK is more volatile compared to AMPH. This indicates higher risk in terms of short-term price fluctuations for MNK.Check AMPH's competition here
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD)
MNK vs IRWD Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, IRWD has a market cap of 711.1M. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while IRWD trades at $4.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas IRWD's P/E ratio is 5.54. In terms of profitability, MNK's ROE is -0.26%, compared to IRWD's ROE of -0.57%. Regarding short-term risk, MNK is more volatile compared to IRWD. This indicates higher risk in terms of short-term price fluctuations for MNK.Check IRWD's competition here
Evotec SE (NASDAQ: EVO)
MNK vs EVO Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, EVO has a market cap of 710.5M. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while EVO trades at $2.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas EVO's P/E ratio is -2.82. In terms of profitability, MNK's ROE is -0.26%, compared to EVO's ROE of -0.24%. Regarding short-term risk, MNK is more volatile compared to EVO. This indicates higher risk in terms of short-term price fluctuations for MNK.Check EVO's competition here
BioDelivery Sciences International, Inc. (NASDAQ: BDSI)
MNK vs BDSI Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, BDSI has a market cap of 577.1M. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while BDSI trades at $5.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas BDSI's P/E ratio is 6.82. In terms of profitability, MNK's ROE is -0.26%, compared to BDSI's ROE of +0.57%. Regarding short-term risk, MNK is more volatile compared to BDSI. This indicates higher risk in terms of short-term price fluctuations for MNK.Check BDSI's competition here
Tilray Brands, Inc. (NASDAQ: TLRY)
MNK vs TLRY Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, TLRY has a market cap of 511.1M. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while TLRY trades at $4.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas TLRY's P/E ratio is -7.21. In terms of profitability, MNK's ROE is -0.26%, compared to TLRY's ROE of -0.08%. Regarding short-term risk, MNK is more volatile compared to TLRY. This indicates higher risk in terms of short-term price fluctuations for MNK.Check TLRY's competition here
Evolus, Inc. (NASDAQ: EOLS)
MNK vs EOLS Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, EOLS has a market cap of 499.8M. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while EOLS trades at $7.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas EOLS's P/E ratio is -24.04. In terms of profitability, MNK's ROE is -0.26%, compared to EOLS's ROE of +1.23%. Regarding short-term risk, MNK is more volatile compared to EOLS. This indicates higher risk in terms of short-term price fluctuations for MNK.Check EOLS's competition here
Aquestive Therapeutics, Inc. (NASDAQ: AQST)
MNK vs AQST Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, AQST has a market cap of 494.3M. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while AQST trades at $3.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas AQST's P/E ratio is -6.46. In terms of profitability, MNK's ROE is -0.26%, compared to AQST's ROE of +1.91%. Regarding short-term risk, MNK is more volatile compared to AQST. This indicates higher risk in terms of short-term price fluctuations for MNK.Check AQST's competition here
Kamada Ltd. (NASDAQ: KMDA)
MNK vs KMDA Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, KMDA has a market cap of 419.4M. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while KMDA trades at $7.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas KMDA's P/E ratio is 20.77. In terms of profitability, MNK's ROE is -0.26%, compared to KMDA's ROE of +0.08%. Regarding short-term risk, MNK is more volatile compared to KMDA. This indicates higher risk in terms of short-term price fluctuations for MNK.Check KMDA's competition here
Canopy Growth Corporation (NASDAQ: CGC)
MNK vs CGC Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, CGC has a market cap of 409.5M. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while CGC trades at $0.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas CGC's P/E ratio is -0.58. In terms of profitability, MNK's ROE is -0.26%, compared to CGC's ROE of -0.31%. Regarding short-term risk, MNK is more volatile compared to CGC. This indicates higher risk in terms of short-term price fluctuations for MNK.Check CGC's competition here
Alpha Teknova, Inc. (NASDAQ: TKNO)
MNK vs TKNO Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, TKNO has a market cap of 346.3M. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while TKNO trades at $6.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas TKNO's P/E ratio is -20.84. In terms of profitability, MNK's ROE is -0.26%, compared to TKNO's ROE of -0.25%. Regarding short-term risk, MNK is more volatile compared to TKNO. This indicates higher risk in terms of short-term price fluctuations for MNK.Check TKNO's competition here
Alimera Sciences, Inc. (NASDAQ: ALIM)
MNK vs ALIM Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, ALIM has a market cap of 301.3M. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while ALIM trades at $5.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas ALIM's P/E ratio is 5.28. In terms of profitability, MNK's ROE is -0.26%, compared to ALIM's ROE of -1.59%. Regarding short-term risk, MNK is more volatile compared to ALIM. This indicates higher risk in terms of short-term price fluctuations for MNK.Check ALIM's competition here
Landec Corporation (NASDAQ: LNDC)
MNK vs LNDC Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, LNDC has a market cap of 263.6M. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while LNDC trades at $8.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas LNDC's P/E ratio is -4.04. In terms of profitability, MNK's ROE is -0.26%, compared to LNDC's ROE of +6.44%. Regarding short-term risk, MNK is more volatile compared to LNDC. This indicates higher risk in terms of short-term price fluctuations for MNK.Check LNDC's competition here
Embecta Corp. (NASDAQ: EMBC)
MNK vs EMBC Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, EMBC has a market cap of 262.2M. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while EMBC trades at $4.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas EMBC's P/E ratio is 1.70. In terms of profitability, MNK's ROE is -0.26%, compared to EMBC's ROE of -0.14%. Regarding short-term risk, MNK is more volatile compared to EMBC. This indicates higher risk in terms of short-term price fluctuations for MNK.Check EMBC's competition here
Organogenesis Holdings Inc. (NASDAQ: ORGO)
MNK vs ORGO Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, ORGO has a market cap of 239.3M. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while ORGO trades at $1.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas ORGO's P/E ratio is 62.00. In terms of profitability, MNK's ROE is -0.26%, compared to ORGO's ROE of -0.27%. Regarding short-term risk, MNK is more volatile compared to ORGO. This indicates higher risk in terms of short-term price fluctuations for MNK.Check ORGO's competition here
Shineco, Inc. (NASDAQ: TYHT)
MNK vs TYHT Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, TYHT has a market cap of 229.2M. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while TYHT trades at $11.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas TYHT's P/E ratio is -1.61. In terms of profitability, MNK's ROE is -0.26%, compared to TYHT's ROE of -0.57%. Regarding short-term risk, MNK is more volatile compared to TYHT. This indicates higher risk in terms of short-term price fluctuations for MNK.Check TYHT's competition here
SIGA Technologies, Inc. (NASDAQ: SIGA)
MNK vs SIGA Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, SIGA has a market cap of 218.8M. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while SIGA trades at $3.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas SIGA's P/E ratio is 11.30. In terms of profitability, MNK's ROE is -0.26%, compared to SIGA's ROE of -0.02%. Regarding short-term risk, MNK is more volatile compared to SIGA. This indicates higher risk in terms of short-term price fluctuations for MNK.Check SIGA's competition here
Lifecore Biomedical, Inc. (NASDAQ: LFCR)
MNK vs LFCR Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, LFCR has a market cap of 187.9M. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while LFCR trades at $5.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas LFCR's P/E ratio is -4.68. In terms of profitability, MNK's ROE is -0.26%, compared to LFCR's ROE of -1.95%. Regarding short-term risk, MNK is more volatile compared to LFCR. This indicates higher risk in terms of short-term price fluctuations for MNK.Check LFCR's competition here
Aurora Cannabis Inc. (NASDAQ: ACB)
MNK vs ACB Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, ACB has a market cap of 185.2M. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while ACB trades at $2.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas ACB's P/E ratio is -6.10. In terms of profitability, MNK's ROE is -0.26%, compared to ACB's ROE of -0.21%. Regarding short-term risk, MNK is more volatile compared to ACB. This indicates higher risk in terms of short-term price fluctuations for MNK.Check ACB's competition here
Recro Pharma, Inc. (NASDAQ: REPH)
MNK vs REPH Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, REPH has a market cap of 177.4M. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while REPH trades at $2.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas REPH's P/E ratio is -8.04. In terms of profitability, MNK's ROE is -0.26%, compared to REPH's ROE of -0.22%. Regarding short-term risk, MNK is more volatile compared to REPH. This indicates higher risk in terms of short-term price fluctuations for MNK.Check REPH's competition here
Journey Medical Corporation (NASDAQ: DERM)
MNK vs DERM Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, DERM has a market cap of 177M. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while DERM trades at $6.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas DERM's P/E ratio is -17.38. In terms of profitability, MNK's ROE is -0.26%, compared to DERM's ROE of -0.36%. Regarding short-term risk, MNK is more volatile compared to DERM. This indicates higher risk in terms of short-term price fluctuations for MNK.Check DERM's competition here
Cardiol Therapeutics Inc. (NASDAQ: CRDL)
MNK vs CRDL Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, CRDL has a market cap of 163.7M. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while CRDL trades at $1.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas CRDL's P/E ratio is -5.05. In terms of profitability, MNK's ROE is -0.26%, compared to CRDL's ROE of -2.29%. Regarding short-term risk, MNK is more volatile compared to CRDL. This indicates higher risk in terms of short-term price fluctuations for MNK.Check CRDL's competition here
Theratechnologies Inc. (NASDAQ: THTX)
MNK vs THTX Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, THTX has a market cap of 155.9M. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while THTX trades at $3.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas THTX's P/E ratio is -28.83. In terms of profitability, MNK's ROE is -0.26%, compared to THTX's ROE of +0.17%. Regarding short-term risk, MNK is more volatile compared to THTX. This indicates higher risk in terms of short-term price fluctuations for MNK.Check THTX's competition here
Assertio Holdings, Inc. (NASDAQ: ASRT)
MNK vs ASRT Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, ASRT has a market cap of 151.9M. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while ASRT trades at $23.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas ASRT's P/E ratio is -7.10. In terms of profitability, MNK's ROE is -0.26%, compared to ASRT's ROE of -0.39%. Regarding short-term risk, MNK is more volatile compared to ASRT. This indicates higher risk in terms of short-term price fluctuations for MNK.Check ASRT's competition here
Organigram Global Inc. (NASDAQ: OGI)
MNK vs OGI Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, OGI has a market cap of 139.4M. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while OGI trades at $0.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas OGI's P/E ratio is -3.81. In terms of profitability, MNK's ROE is -0.26%, compared to OGI's ROE of -0.07%. Regarding short-term risk, MNK is more volatile compared to OGI. This indicates higher risk in terms of short-term price fluctuations for MNK.Check OGI's competition here
Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX)
MNK vs CPIX Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, CPIX has a market cap of 116.9M. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while CPIX trades at $7.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas CPIX's P/E ratio is -19.50. In terms of profitability, MNK's ROE is -0.26%, compared to CPIX's ROE of -0.47%. Regarding short-term risk, MNK is more volatile compared to CPIX. This indicates higher risk in terms of short-term price fluctuations for MNK.Check CPIX's competition here
Societal CDMO, Inc. (NASDAQ: SCTL)
MNK vs SCTL Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, SCTL has a market cap of 116.1M. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while SCTL trades at $1.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas SCTL's P/E ratio is -7.86. In terms of profitability, MNK's ROE is -0.26%, compared to SCTL's ROE of -0.22%. Regarding short-term risk, MNK is more volatile compared to SCTL. This indicates higher risk in terms of short-term price fluctuations for MNK.Check SCTL's competition here
Procaps Group S.A. (NASDAQ: PROC)
MNK vs PROC Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, PROC has a market cap of 102.1M. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while PROC trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas PROC's P/E ratio is 1.53. In terms of profitability, MNK's ROE is -0.26%, compared to PROC's ROE of -2.22%. Regarding short-term risk, MNK is more volatile compared to PROC. This indicates higher risk in terms of short-term price fluctuations for MNK.Check PROC's competition here
OptiNose, Inc. (NASDAQ: OPTN)
MNK vs OPTN Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, OPTN has a market cap of 97.2M. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while OPTN trades at $9.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas OPTN's P/E ratio is -4.42. In terms of profitability, MNK's ROE is -0.26%, compared to OPTN's ROE of +0.34%. Regarding short-term risk, MNK is more volatile compared to OPTN. This indicates higher risk in terms of short-term price fluctuations for MNK.Check OPTN's competition here
Zomedica Corp. (AMEX: ZOM)
MNK vs ZOM Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, ZOM has a market cap of 95.3M. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while ZOM trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas ZOM's P/E ratio is -1.62. In terms of profitability, MNK's ROE is -0.26%, compared to ZOM's ROE of -0.17%. Regarding short-term risk, MNK is more volatile compared to ZOM. This indicates higher risk in terms of short-term price fluctuations for MNK.Check ZOM's competition here
Zhengye Biotechnology Holding Limited (NASDAQ: ZYBT)
MNK vs ZYBT Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, ZYBT has a market cap of 89.6M. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while ZYBT trades at $1.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas ZYBT's P/E ratio is -8.59. In terms of profitability, MNK's ROE is -0.26%, compared to ZYBT's ROE of -0.27%. Regarding short-term risk, MNK is less volatile compared to ZYBT. This indicates lower risk in terms of short-term price fluctuations for MNK.Check ZYBT's competition here
Upexi, Inc. (NASDAQ: GRVI)
MNK vs GRVI Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, GRVI has a market cap of 88.9M. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while GRVI trades at $4.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas GRVI's P/E ratio is 26.05. In terms of profitability, MNK's ROE is -0.26%, compared to GRVI's ROE of -2.54%. Regarding short-term risk, MNK is more volatile compared to GRVI. This indicates higher risk in terms of short-term price fluctuations for MNK.Check GRVI's competition here
Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE)
MNK vs ZYNE Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, ZYNE has a market cap of 70.1M. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while ZYNE trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas ZYNE's P/E ratio is -1.65. In terms of profitability, MNK's ROE is -0.26%, compared to ZYNE's ROE of -0.59%. Regarding short-term risk, MNK is more volatile compared to ZYNE. This indicates higher risk in terms of short-term price fluctuations for MNK.Check ZYNE's competition here
Silver Spike Investment Corp. (NASDAQ: SSIC)
MNK vs SSIC Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, SSIC has a market cap of 66.7M. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while SSIC trades at $10.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas SSIC's P/E ratio is 11.93. In terms of profitability, MNK's ROE is -0.26%, compared to SSIC's ROE of +0.00%. Regarding short-term risk, MNK is more volatile compared to SSIC. This indicates higher risk in terms of short-term price fluctuations for MNK.Check SSIC's competition here
The Valens Company Inc. (NASDAQ: VLNS)
MNK vs VLNS Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, VLNS has a market cap of 61.5M. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while VLNS trades at $0.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas VLNS's P/E ratio is -1.03. In terms of profitability, MNK's ROE is -0.26%, compared to VLNS's ROE of N/A. Regarding short-term risk, MNK is more volatile compared to VLNS. This indicates higher risk in terms of short-term price fluctuations for MNK.Check VLNS's competition here
BGM Group Ltd. (NASDAQ: BGM)
MNK vs BGM Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, BGM has a market cap of 60.3M. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while BGM trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas BGM's P/E ratio is -1.04. In terms of profitability, MNK's ROE is -0.26%, compared to BGM's ROE of -0.07%. Regarding short-term risk, MNK is more volatile compared to BGM. This indicates higher risk in terms of short-term price fluctuations for MNK.Check BGM's competition here
DURECT Corporation (NASDAQ: DRRX)
MNK vs DRRX Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, DRRX has a market cap of 59.3M. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while DRRX trades at $1.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas DRRX's P/E ratio is -4.44. In terms of profitability, MNK's ROE is -0.26%, compared to DRRX's ROE of -1.40%. Regarding short-term risk, MNK is more volatile compared to DRRX. This indicates higher risk in terms of short-term price fluctuations for MNK.Check DRRX's competition here
InterCure Ltd. (NASDAQ: INCR)
MNK vs INCR Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, INCR has a market cap of 58M. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while INCR trades at $0.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas INCR's P/E ratio is -2.26. In terms of profitability, MNK's ROE is -0.26%, compared to INCR's ROE of -0.09%. Regarding short-term risk, MNK is more volatile compared to INCR. This indicates higher risk in terms of short-term price fluctuations for MNK.Check INCR's competition here
Jupiter Wellness, Inc. (NASDAQ: JUPW)
MNK vs JUPW Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, JUPW has a market cap of 49.3M. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while JUPW trades at $1.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas JUPW's P/E ratio is -2.41. In terms of profitability, MNK's ROE is -0.26%, compared to JUPW's ROE of -1.94%. Regarding short-term risk, MNK is more volatile compared to JUPW. This indicates higher risk in terms of short-term price fluctuations for MNK.Check JUPW's competition here
Qilian International Holding Group Limited (NASDAQ: QLI)
MNK vs QLI Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, QLI has a market cap of 38.7M. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while QLI trades at $5.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas QLI's P/E ratio is -4.92. In terms of profitability, MNK's ROE is -0.26%, compared to QLI's ROE of -0.16%. Regarding short-term risk, MNK is more volatile compared to QLI. This indicates higher risk in terms of short-term price fluctuations for MNK.Check QLI's competition here
HEXO Corp. (NASDAQ: HEXO)
MNK vs HEXO Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, HEXO has a market cap of 31.2M. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while HEXO trades at $0.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas HEXO's P/E ratio is -0.26. In terms of profitability, MNK's ROE is -0.26%, compared to HEXO's ROE of -2.06%. Regarding short-term risk, MNK is more volatile compared to HEXO. This indicates higher risk in terms of short-term price fluctuations for MNK.Check HEXO's competition here
Talphera, Inc. (NASDAQ: TLPH)
MNK vs TLPH Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, TLPH has a market cap of 29.3M. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while TLPH trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas TLPH's P/E ratio is -4.61. In terms of profitability, MNK's ROE is -0.26%, compared to TLPH's ROE of -0.93%. Regarding short-term risk, MNK is more volatile compared to TLPH. This indicates higher risk in terms of short-term price fluctuations for MNK.Check TLPH's competition here
Rockwell Medical, Inc. (NASDAQ: RMTI)
MNK vs RMTI Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, RMTI has a market cap of 28.5M. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while RMTI trades at $7.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas RMTI's P/E ratio is -6.89. In terms of profitability, MNK's ROE is -0.26%, compared to RMTI's ROE of -0.15%. Regarding short-term risk, MNK is more volatile compared to RMTI. This indicates higher risk in terms of short-term price fluctuations for MNK.Check RMTI's competition here
Aytu BioPharma, Inc. (NASDAQ: AYTU)
MNK vs AYTU Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, AYTU has a market cap of 25.3M. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while AYTU trades at $2.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas AYTU's P/E ratio is -1.23. In terms of profitability, MNK's ROE is -0.26%, compared to AYTU's ROE of -1.49%. Regarding short-term risk, MNK is more volatile compared to AYTU. This indicates higher risk in terms of short-term price fluctuations for MNK.Check AYTU's competition here
TherapeuticsMD, Inc. (NASDAQ: TXMD)
MNK vs TXMD Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, TXMD has a market cap of 24M. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while TXMD trades at $2.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas TXMD's P/E ratio is 105.45. In terms of profitability, MNK's ROE is -0.26%, compared to TXMD's ROE of +0.01%. Regarding short-term risk, MNK is more volatile compared to TXMD. This indicates higher risk in terms of short-term price fluctuations for MNK.Check TXMD's competition here
Cyclo Therapeutics, Inc. (NASDAQ: CYTH)
MNK vs CYTH Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, CYTH has a market cap of 23.6M. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while CYTH trades at $0.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas CYTH's P/E ratio is -0.80. In terms of profitability, MNK's ROE is -0.26%, compared to CYTH's ROE of -7.30%. Regarding short-term risk, MNK is more volatile compared to CYTH. This indicates higher risk in terms of short-term price fluctuations for MNK.Check CYTH's competition here
Evoke Pharma, Inc. (NASDAQ: EVOK)
MNK vs EVOK Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, EVOK has a market cap of 18.9M. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while EVOK trades at $11.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas EVOK's P/E ratio is -7.97. In terms of profitability, MNK's ROE is -0.26%, compared to EVOK's ROE of -0.89%. Regarding short-term risk, MNK is more volatile compared to EVOK. This indicates higher risk in terms of short-term price fluctuations for MNK.Check EVOK's competition here
Biofrontera Inc. (NASDAQ: BFRIW)
MNK vs BFRIW Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, BFRIW has a market cap of 17M. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while BFRIW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas BFRIW's P/E ratio is -0.03. In terms of profitability, MNK's ROE is -0.26%, compared to BFRIW's ROE of -4.77%. Regarding short-term risk, MNK is more volatile compared to BFRIW. This indicates higher risk in terms of short-term price fluctuations for MNK.Check BFRIW's competition here
Optimi Health Corp. (NASDAQ: OPTH)
MNK vs OPTH Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, OPTH has a market cap of 16.3M. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while OPTH trades at $5.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas OPTH's P/E ratio is -18.56. In terms of profitability, MNK's ROE is -0.26%, compared to OPTH's ROE of -0.94%. Regarding short-term risk, MNK is more volatile compared to OPTH. This indicates higher risk in terms of short-term price fluctuations for MNK.Check OPTH's competition here
AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX)
MNK vs ACRX Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, ACRX has a market cap of 14.6M. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while ACRX trades at $0.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas ACRX's P/E ratio is -0.31. In terms of profitability, MNK's ROE is -0.26%, compared to ACRX's ROE of -0.93%. Regarding short-term risk, MNK is more volatile compared to ACRX. This indicates higher risk in terms of short-term price fluctuations for MNK.Check ACRX's competition here
Cosmos Health Inc. (NASDAQ: COSM)
MNK vs COSM Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, COSM has a market cap of 12.7M. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while COSM trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas COSM's P/E ratio is -0.38. In terms of profitability, MNK's ROE is -0.26%, compared to COSM's ROE of -0.96%. Regarding short-term risk, MNK is more volatile compared to COSM. This indicates higher risk in terms of short-term price fluctuations for MNK.Check COSM's competition here
Agile Therapeutics, Inc. (NASDAQ: AGRX)
MNK vs AGRX Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, AGRX has a market cap of 10.4M. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while AGRX trades at $1.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas AGRX's P/E ratio is -0.89. In terms of profitability, MNK's ROE is -0.26%, compared to AGRX's ROE of +1.32%. Regarding short-term risk, MNK is more volatile compared to AGRX. This indicates higher risk in terms of short-term price fluctuations for MNK.Check AGRX's competition here
Neoleukin Therapeutics, Inc. (NASDAQ: NLTX)
MNK vs NLTX Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, NLTX has a market cap of 8.2M. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while NLTX trades at $3.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas NLTX's P/E ratio is -0.28. In terms of profitability, MNK's ROE is -0.26%, compared to NLTX's ROE of -0.38%. Regarding short-term risk, MNK is more volatile compared to NLTX. This indicates higher risk in terms of short-term price fluctuations for MNK.Check NLTX's competition here
Lannett Company, Inc. (NYSE: LCI)
MNK vs LCI Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, LCI has a market cap of 7.4M. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while LCI trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas LCI's P/E ratio is -0.04. In terms of profitability, MNK's ROE is -0.26%, compared to LCI's ROE of +1.66%. Regarding short-term risk, MNK is more volatile compared to LCI. This indicates higher risk in terms of short-term price fluctuations for MNK.Check LCI's competition here
Adamis Pharmaceuticals Corporation (NASDAQ: ADMP)
MNK vs ADMP Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, ADMP has a market cap of 7.3M. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while ADMP trades at $0.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas ADMP's P/E ratio is -0.08. In terms of profitability, MNK's ROE is -0.26%, compared to ADMP's ROE of -2.09%. Regarding short-term risk, MNK is more volatile compared to ADMP. This indicates higher risk in terms of short-term price fluctuations for MNK.Check ADMP's competition here
cbdMD, Inc. (AMEX: YCBD)
MNK vs YCBD Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, YCBD has a market cap of 5.9M. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while YCBD trades at $0.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas YCBD's P/E ratio is -1.38. In terms of profitability, MNK's ROE is -0.26%, compared to YCBD's ROE of -0.34%. Regarding short-term risk, MNK is more volatile compared to YCBD. This indicates higher risk in terms of short-term price fluctuations for MNK.Check YCBD's competition here
Gelteq Limited Ordinary Shares (NASDAQ: GELS)
MNK vs GELS Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, GELS has a market cap of 5M. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while GELS trades at $0.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas GELS's P/E ratio is -1.09. In terms of profitability, MNK's ROE is -0.26%, compared to GELS's ROE of -0.25%. Regarding short-term risk, MNK is more volatile compared to GELS. This indicates higher risk in terms of short-term price fluctuations for MNK.Check GELS's competition here
Flora Growth Corp. (NASDAQ: FLGC)
MNK vs FLGC Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, FLGC has a market cap of 4.2M. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while FLGC trades at $7.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas FLGC's P/E ratio is -0.19. In terms of profitability, MNK's ROE is -0.26%, compared to FLGC's ROE of -3.03%. Regarding short-term risk, MNK is less volatile compared to FLGC. This indicates lower risk in terms of short-term price fluctuations for MNK.Check FLGC's competition here
China Pharma Holdings, Inc. (AMEX: CPHI)
MNK vs CPHI Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, CPHI has a market cap of 3.6M. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while CPHI trades at $1.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas CPHI's P/E ratio is -1.76. In terms of profitability, MNK's ROE is -0.26%, compared to CPHI's ROE of -0.19%. Regarding short-term risk, MNK is more volatile compared to CPHI. This indicates higher risk in terms of short-term price fluctuations for MNK.Check CPHI's competition here
Universe Pharmaceuticals Inc. (NASDAQ: UPC)
MNK vs UPC Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, UPC has a market cap of 3.5M. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while UPC trades at $5.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas UPC's P/E ratio is -0.69. In terms of profitability, MNK's ROE is -0.26%, compared to UPC's ROE of -0.03%. Regarding short-term risk, MNK is more volatile compared to UPC. This indicates higher risk in terms of short-term price fluctuations for MNK.Check UPC's competition here
Sunshine Biopharma, Inc. (NASDAQ: SBFM)
MNK vs SBFM Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, SBFM has a market cap of 2.9M. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while SBFM trades at $1.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas SBFM's P/E ratio is -0.20. In terms of profitability, MNK's ROE is -0.26%, compared to SBFM's ROE of -0.26%. Regarding short-term risk, MNK is more volatile compared to SBFM. This indicates higher risk in terms of short-term price fluctuations for MNK.Check SBFM's competition here
Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH)
MNK vs SHPH Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, SHPH has a market cap of 2.6M. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while SHPH trades at $4.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas SHPH's P/E ratio is -0.20. In terms of profitability, MNK's ROE is -0.26%, compared to SHPH's ROE of -4.08%. Regarding short-term risk, MNK is more volatile compared to SHPH. This indicates higher risk in terms of short-term price fluctuations for MNK.Check SHPH's competition here
PLx Pharma Inc. (NASDAQ: PLXP)
MNK vs PLXP Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, PLXP has a market cap of 2.5M. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while PLXP trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas PLXP's P/E ratio is -0.22. In terms of profitability, MNK's ROE is -0.26%, compared to PLXP's ROE of -1.66%. Regarding short-term risk, MNK is less volatile compared to PLXP. This indicates lower risk in terms of short-term price fluctuations for MNK.Check PLXP's competition here
Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA)
MNK vs SNOA Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, SNOA has a market cap of 2.4M. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while SNOA trades at $1.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas SNOA's P/E ratio is -1.22. In terms of profitability, MNK's ROE is -0.26%, compared to SNOA's ROE of -0.54%. Regarding short-term risk, MNK is more volatile compared to SNOA. This indicates higher risk in terms of short-term price fluctuations for MNK.Check SNOA's competition here
Athenex, Inc. (NASDAQ: ATNX)
MNK vs ATNX Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, ATNX has a market cap of 2.3M. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while ATNX trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas ATNX's P/E ratio is -0.02. In terms of profitability, MNK's ROE is -0.26%, compared to ATNX's ROE of +0.22%. Regarding short-term risk, MNK is more volatile compared to ATNX. This indicates higher risk in terms of short-term price fluctuations for MNK.Check ATNX's competition here
Procaps Group, S.A. (NASDAQ: PROCW)
MNK vs PROCW Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, PROCW has a market cap of 2M. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while PROCW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas PROCW's P/E ratio is N/A. In terms of profitability, MNK's ROE is -0.26%, compared to PROCW's ROE of -2.22%. Regarding short-term risk, MNK is more volatile compared to PROCW. This indicates higher risk in terms of short-term price fluctuations for MNK.Check PROCW's competition here
RedHill Biopharma Ltd. (NASDAQ: RDHL)
MNK vs RDHL Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, RDHL has a market cap of 1.9M. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while RDHL trades at $0.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas RDHL's P/E ratio is 0.12. In terms of profitability, MNK's ROE is -0.26%, compared to RDHL's ROE of +57.40%. Regarding short-term risk, MNK is more volatile compared to RDHL. This indicates higher risk in terms of short-term price fluctuations for MNK.Check RDHL's competition here
cbdMD, Inc. (AMEX: YCBD-PA)
MNK vs YCBD-PA Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, YCBD-PA has a market cap of 928.2K. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while YCBD-PA trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas YCBD-PA's P/E ratio is -2.69. In terms of profitability, MNK's ROE is -0.26%, compared to YCBD-PA's ROE of -0.34%. Regarding short-term risk, MNK is more volatile compared to YCBD-PA. This indicates higher risk in terms of short-term price fluctuations for MNK.Check YCBD-PA's competition here
Cyclo Therapeutics, Inc. (NASDAQ: CYTHW)
MNK vs CYTHW Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, CYTHW has a market cap of 928K. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while CYTHW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas CYTHW's P/E ratio is N/A. In terms of profitability, MNK's ROE is -0.26%, compared to CYTHW's ROE of -7.30%. Regarding short-term risk, MNK is more volatile compared to CYTHW. This indicates higher risk in terms of short-term price fluctuations for MNK.Check CYTHW's competition here
Lucy Scientific Discovery Inc. (NASDAQ: LSDI)
MNK vs LSDI Comparison August 2026
Mallinckrodt plc (AMEX: MNK) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, LSDI has a market cap of 906.9K. Regarding current trading prices, MNK is priced at $0.34 on the AMEX, while LSDI trades at $0.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas LSDI's P/E ratio is -0.07. In terms of profitability, MNK's ROE is -0.26%, compared to LSDI's ROE of +181.47%. Regarding short-term risk, MNK is less volatile compared to LSDI. This indicates lower risk in terms of short-term price fluctuations for MNK.Check LSDI's competition here